Use the Back button in your browser to see the other results of your search or to select another record.
Detailed Search Results
| Use of flutter VRP1 in the management of patients with steroid-dependent asthma |
| Swift GL, Rainer T, Saran R, Campbell IA, Prescott RJ |
| Respiration 1994;61(3):126-129 |
| clinical trial |
| 5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
We have assessed a new positive expiratory pressure device, the Flutter VRP1, in 20 patients with moderately severe asthma. Patients were studied for an initial 1-week 'run-in' period, followed by 2 weeks of the flutter device in one of which the ball-bearing was removed from the bowl. Peak expiratory flow rates, salbutamol inhaler requirements and visual analogue scores were recorded daily. Ease of sputum expectoration showed a significant improvement after 6 days of the flutter device, but there were no differences in objective measurements of lung function nor in salbutamol use. The device may be a useful adjunct to asthma therapy.
|
The database was last updated on 3 November 2025 (this includes records added or amended since 3 October 2025). The next update is planned for 5 January 2026. The total number of records on the database is 66,595.